Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.31 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23313726 | 0.96 | PLA2G2A (0.31) | PLA2G2APLA2G4AALOX5NPC1CYP1A2 | |
| SCHEMBL23180413 | 0.96 | PLA2G2A (0.33) | PLA2G2APLA2G4AS1PR4S1PR5ALOX5 | |
| SCHEMBL23313667 | 0.94 | PLA2G2A (0.31) | PLA2G2APLA2G4AS1PR4S1PR5ALOX5 | |
| SCHEMBL24919194 | 0.94 | CYP1A2 (0.31) | ALOX5NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23313334 | 0.94 | PLA2G2A (0.34) | PLA2G2APLA2G4AALOX5RAB9A | |
| SCHEMBL23313822 | 0.94 | PLA2G2A (0.34) | PLA2G2APLA2G4AALOX5RAB9A | |
| SCHEMBL23180197 | 0.93 | NPC1 (0.33) | PLA2G2APLA2G4AS1PR4S1PR5ALOX5 | |
| SCHEMBL23180746 | 0.93 | NPC1 (0.33) | PLA2G2APLA2G4AS1PR4S1PR5ALOX5 | |
| SCHEMBL25731275 | 0.92 | MCL1 (0.30) | PLA2G2APLA2G4ACYP1A2 | |
| SCHEMBL23867388 | 0.91 | RAB9A (0.34) | S1PR4S1PR5ALOX5ANO1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210126197-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210126197-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, L1CAM, AOC1 | PLA2G2A 3998/4885PLA2G4A 4361/4885S1PR4 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.